Monopar Therapeutics (MNPR) has 9 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 2 sales totalling $807K. Most recent filing: Aug. 28, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 28, 2026 filed Aug. 26, 2026 | Tsuchimoto Kim R Director | $332,867 | 12,270 | 0% | Yes | |
|
|
||||||
| Aug. 28, 2026 filed Aug. 25, 2026 | Anderson Raymond Director | $257,575 | 9,426 | 0% | Yes | |
|
|
||||||
| Aug. 27, 2026 filed Aug. 26, 2026 | RIOUX PATRICE Insider | — | +1,379 | — | Yes | |
|
|
||||||
| Aug. 27, 2026 filed Aug. 25, 2026 | Anderson Raymond Director | −$351,189 | 3,142 | −12% | Yes | |
|
|
||||||
| Aug. 27, 2026 filed Aug. 26, 2026 | Tsuchimoto Kim R Director | −$455,567 | 4,090 | −36% | Yes | |
|
|
||||||
Showing the 5 most recent of 9 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free